ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Sevilla, AN, ESP:

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: Palbociclib
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Sevilla, Spain and 72 other locations

in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases.This study will ana...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Trastuzumab-Deruxtecan (T-DXd)

Phase 2

MedSIR

Sevilla, Spain and 11 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Active, not recruiting
Breast Cancer
Locally Advanced Breast Cancer
Drug: Elacestrant Dihydrochloride
Drug: Samuraciclib

Phase 1, Phase 2

Carrick Therapeutics

Sevilla, Spain and 22 other locations

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this stud...

Enrolling
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

Phase 3

ETOP IBCSG Partners Foundation

Sevilla, Spain and 52 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Sevilla, Spain and 16 other locations

the primary and metastatic (or relapsed) tumor will be collected for central analyses, together with blood, serum and plasma samples. Any s ...

Enrolling
Metastatic Breast Cancer
Procedure: metastatic lesion biopsy
Breast International Group

Sevilla, Spain and 51 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Seville, Spain and 117 other locations

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Sevilla, Spain and 71 other locations

number of mutations per coding area of a tumor genome). The HER2-E and Basal-like profiles have been associated with high mutational burden ...

Enrolling
Breast Cancer
Drug: Atezolizumab + Trastuzumab + Vinorelbine

Phase 2

SOLTI

Sevilla, Spain and 14 other locations

This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...

Active, not recruiting
Breast Cancer
Combination Product: Neoadjuvant combination therapy with olaparib plus durvalumab
Drug: Neoadjuvant Olaparib monotherapy group

Phase 2

AstraZeneca
AstraZeneca

Sevilla, Spain and 43 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems